The round was led by Froedtert Health, UNC Health, LCMC Health, and University Hospitals, with participation from Rev1 Ventures, Nationwide Children’s Hospital and Cincinnati Children’s Hospital.
The company intends to use the funds to support its expansion plans to build a second facility in Columbus.
Led by CEO Joe Bagan, STAQ Pharma produces sterile to sterile and non-sterile to sterile compounded medications and leverages automation to ensure adequate supply and compliance with FDA regulations. It is an FDA Registered 503B Outsourcing Facility that produces Sterile Injectable medications compounded under the Current Good Manufacturing Practices (cGMP) standards of pharmaceutical production.
STAQ Pharma will begin design, architecture, and construction planning efforts immediately in the western part of Columbus. At full capacity, STAQ Pharma plans to employ up to 300 people at this facility.
FinSMEs
07/03/2022